
FDA Approves Revolutionary Twice-a-Year HIV Shot
The FDA approves a revolutionary twice-a-year HIV shot by Gilead, signaling a new era in global HIV prevention.
Stay informed, stay connected—news for amigos everywhere.
The FDA approves a revolutionary twice-a-year HIV shot by Gilead, signaling a new era in global HIV prevention.
The Trump administration has initiated mass layoffs across key U.S. health agencies, affecting 10,000 staffers and sparking major concerns.